For example, in a study involving 173 survivors of testicular cancer, genetic variants of glutathione S-transferase (GST) are described as a key determinant of cisplatin-induced ototoxicity: the GSTM1 polymorphism is described as detrimental and 105Val-GSTP1 described as protective [104]. This evidence concerns the gene GSTM1 and testicular cancer.